Atlas Trials

Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer

Clinical trial NCT07271823 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07271823
Sponsor
Zhejiang Cancer Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Pancreatic Cancer Non-resectable
Start date
2024-09-01
Primary completion
2026-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.